231 related articles for article (PubMed ID: 26463425)
61. FOXP3-positive T-cell lymphomas in non-HTLV1 carriers include ALK-negative anaplastic large cell lymphoma: expanding the spectrum of T-cell lymphomas with regulatory phenotype.
Ferreira CR; Zhao S; Sahoo MK; Pinsky B; Weber J; Lage LAPC; Pereira J; Zerbini MCN; Natkunam Y
Hum Pathol; 2018 Oct; 80():138-144. PubMed ID: 29898383
[TBL] [Abstract][Full Text] [Related]
62. Genetic Subtypes of Systemic Anaplastic Large Cell Lymphoma Show Distinct Differences in PD-L1 Expression and Regulatory and Cytotoxic T Cells in the Tumor Microenvironment.
Ferreira CR; Manohar V; Zhao S; Bangs CD; Cherry A; Azevedo RS; Lage LAPC; Pereira J; Zerbini MCN; Gratzinger D; Natkunam Y
Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):10-16. PubMed ID: 31809310
[TBL] [Abstract][Full Text] [Related]
63. ALK+ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation.
Dejean E; Foisseau M; Lagarrigue F; Lamant L; Prade N; Marfak A; Delsol G; Giuriato S; Gaits-Iacovoni F; Meggetto F
Blood; 2012 May; 119(20):4698-707. PubMed ID: 22394598
[TBL] [Abstract][Full Text] [Related]
64. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers.
Cheng M; Quail MR; Gingrich DE; Ott GR; Lu L; Wan W; Albom MS; Angeles TS; Aimone LD; Cristofani F; Machiorlatti R; Abele C; Ator MA; Dorsey BD; Inghirami G; Ruggeri BA
Mol Cancer Ther; 2012 Mar; 11(3):670-9. PubMed ID: 22203728
[TBL] [Abstract][Full Text] [Related]
65. MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression.
Vishwamitra D; Li Y; Wilson D; Manshouri R; Curry CV; Shi B; Tang XM; Sheehan AM; Wistuba II; Shi P; Amin HM
Am J Pathol; 2012 May; 180(5):1772-80. PubMed ID: 22414602
[TBL] [Abstract][Full Text] [Related]
66. Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma.
Kutok JL; Aster JC
J Clin Oncol; 2002 Sep; 20(17):3691-702. PubMed ID: 12202671
[TBL] [Abstract][Full Text] [Related]
67. [Anaplastic large cell lymphoma: an array-based comparative genomic hybridization study].
Wang M; Liu R; Su LY; Yu R; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):580-3. PubMed ID: 24314241
[TBL] [Abstract][Full Text] [Related]
68. Identification of C/EBPβ target genes in ALK+ anaplastic large cell lymphoma (ALCL) by gene expression profiling and chromatin immunoprecipitation.
Bonzheim I; Irmler M; Klier-Richter M; Steinhilber J; Anastasov N; Schäfer S; Adam P; Beckers J; Raffeld M; Fend F; Quintanilla-Martinez L
PLoS One; 2013; 8(5):e64544. PubMed ID: 23741337
[TBL] [Abstract][Full Text] [Related]
69. [Expressions and clinical significance of GAS1, IL-1RAP and PRF1 in patients with ALK positive anaplastic large cell lymphoma].
Jiang Y; Cao D; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2018 Feb; 39(2):116-121. PubMed ID: 29562445
[No Abstract] [Full Text] [Related]
70. Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?
Fornari A; Piva R; Chiarle R; Novero D; Inghirami G
Hematol Oncol; 2009 Dec; 27(4):161-70. PubMed ID: 19358142
[TBL] [Abstract][Full Text] [Related]
71. The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK
Fragliasso V; Verma A; Manzotti G; Tameni A; Bareja R; Heavican TB; Iqbal J; Wang R; Fiore D; Mularoni V; Chan WC; Lhoumaud P; Skok J; Zanetti E; Merli F; Ciarrocchi A; Elemento O; Inghirami G
Leukemia; 2020 Nov; 34(11):2964-2980. PubMed ID: 32123306
[TBL] [Abstract][Full Text] [Related]
72. CD147 a direct target of miR-146a supports energy metabolism and promotes tumor growth in ALK+ ALCL.
Montes-Mojarro IA; Steinhilber J; Griessinger CM; Rau A; Gersmann AK; Kohlhofer U; Fallier-Becker P; Liang HC; Hofmann U; Haag M; Klapper W; Schaeffeler E; Pichler BJ; Schwab M; Fend F; Bonzheim I; Quintanilla-Martinez L
Leukemia; 2022 Aug; 36(8):2050-2063. PubMed ID: 35676454
[TBL] [Abstract][Full Text] [Related]
73. Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma.
Weilemann A; Grau M; Erdmann T; Merkel O; Sobhiafshar U; Anagnostopoulos I; Hummel M; Siegert A; Hayford C; Madle H; Wollert-Wulf B; Fichtner I; Dörken B; Dirnhofer S; Mathas S; Janz M; Emre NC; Rosenwald A; Ott G; Lenz P; Tzankov A; Lenz G
Blood; 2015 Jan; 125(1):124-32. PubMed ID: 25359993
[TBL] [Abstract][Full Text] [Related]
74. Twenty years of modelling NPM-ALK-induced lymphomagenesis.
Giuriato S; Turner SD
Front Biosci (Schol Ed); 2015 Jun; 7(2):236-47. PubMed ID: 25961699
[TBL] [Abstract][Full Text] [Related]
75. p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma.
Richardson AI; Yin CC; Cui W; Li N; Medeiros LJ; Li L; Zhang D
Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e385-e392. PubMed ID: 31078446
[TBL] [Abstract][Full Text] [Related]
76. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
Xing X; Feldman AL
Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779
[TBL] [Abstract][Full Text] [Related]
77. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
78. Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma.
Singh RR; Cho-Vega JH; Davuluri Y; Ma S; Kasbidi F; Milito C; Lennon PA; Drakos E; Medeiros LJ; Luthra R; Vega F
Cancer Res; 2009 Mar; 69(6):2550-8. PubMed ID: 19244133
[TBL] [Abstract][Full Text] [Related]
79. Aggressive transformation of anaplastic large cell lymphoma with increased number of ALK-translocated chromosomes.
Hoshino A; Nomura K; Hamashima T; Isobe T; Seki M; Hiwatari M; Yoshida K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Takita J; Kanegane H
Int J Hematol; 2015 Feb; 101(2):198-202. PubMed ID: 25416234
[TBL] [Abstract][Full Text] [Related]
80. Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma.
Cho-Vega JH; Rassidakis GZ; Amin HM; Tsioli P; Spurgers K; Remache YK; Vega F; Goy AH; Gilles F; Medeiros LJ
Leukemia; 2004 Nov; 18(11):1872-8. PubMed ID: 15385932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]